Bydureon Goes Back To The QTc Drawing Board

Amylin considers options for new study assessing cardiac safety, estimates resubmission timeline by year-end 2011.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet